Expresso highlights Fetalix’s innovative approach to intervertebral disc regeneration
Fetalix has been featured in Expresso in the article “A Costa das Dores”, which explores new perspectives and solutions for pain-related healthcare challenges. The piece highlights Fetalix’s technology and its potential role in advancing treatment options for low back pain.
Fetalix strengthens innovation pathway through licensing agreement
Technology licensing plays a key role in translating academic research into real-world healthcare solutions, enabling scientific discoveries to progress from the laboratory toward clinical and commercial application.
The science behind Fetalix published in Biomaterials Advances
The PhD research of our co-founder, Morena Francesca Fiordalisi, was published in Biomaterials Advances. The study investigates how the age of the donor tissue used to derive extracellular matrix (ECM) biomaterials influences intervertebral disc regeneration.
